InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
17,060.40
(
0.00%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.54
(
0.36%
)
Bitcoin
64,056.69
(
-0.35%
)
Post# of 2794
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ellebi1

Send PM Follow Ignore
Followers 0
Posts 2
Boards Moderated 0
Alias Born 03/14/2020

ellebi1

Re: None

Tuesday, 03/17/2020 10:30:45 AM

Tuesday, March 17, 2020 10:30:45 AM

Post# of 2794
Actinium Pharmaceuticals FDA filing expected in early 2020.

Actinium Pharmaceuticals Inc CEO Sandesh Seth tells Proactive's Christine Corrado the biotech's flagship cancer fighting drug,
Iomab-B, is currently in Phase 3, with results expected this fall, and an FDA filing expected in early 2020.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ATNM News
More ATNM News
InvestorsHub NewsWire

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM

Start posting your company's news
Only $200 per official company press release!